SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-014621
Filing Date
2024-11-06
Accepted
2024-11-06 16:10:58
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20241106x8k.htm   iXBRL 8-K 36373
2 EX-99.1 gbio-20241106xex99d1.htm EX-99.1 64946
3 GRAPHIC gbio-20241106xex99d1001.jpg GRAPHIC 6132
  Complete submission text file 0001558370-24-014621.txt   238424

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20241106.xsd EX-101.SCH 3996
5 EX-101.DEF gbio-20241106_def.xml EX-101.DEF 2737
6 EX-101.LAB gbio-20241106_lab.xml EX-101.LAB 13969
7 EX-101.PRE gbio-20241106_pre.xml EX-101.PRE 10835
18 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20241106x8k_htm.xml XML 4660
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 241431036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)